Ignite Creation Date:
2024-05-06 @ 7:52 PM
Last Modification Date:
2024-10-26 @ 3:15 PM
Study NCT ID:
NCT06160206
Status:
NOT_YET_RECRUITING
Last Update Posted:
2023-12-07
First Post:
2023-11-29
Brief Title:
Retifanlimab with Bevacizumab and Hypofractionated Radiotherapy for the Treatment of Recurrent Glioblastoma
Sponsor:
Organization:
Academic and Community Cancer Research United